Recombinant FLT1 (Icrucumab Biosimilar) antibody

Catalog No. ABIN7490992

The Human Monoclonal anti-FLT1 (Icrucumab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect FLT1 (Icrucumab Biosimilar) in samples from Human.

Quick Overview for Recombinant FLT1 (Icrucumab Biosimilar) antibody (ABIN7490992)

Target: FLT1 (Icrucumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This FLT1 (Icrucumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-FLT1 (Icrucumab Biosimilar) Antibody

Purpose: Anti-FLT1 (icrucumab biosimilar) mAb

Characteristics: 18F1, IMC-18F1, LY3012212

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for FLT1 (Icrucumab Biosimilar)

Target: FLT1 (Icrucumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: FLT, FLT-1, VEGFR-1, VEGFR1

UniProt: P17948